Welcome to the official website of BioCoreUSA Corp!
home > TISSUE ARRAYS > Liver > DLV1481
  • Cores:
    148
    CASES:
    74
    Core Diameter(mm):
    2
    Thickness(µm):
    5
    Row number:
    10
    Column number:
    15
    Tissue Array Type:
    FFPE
    Species:
    Human
DLV1481
$255.00
Add To Collect

Description: Liver cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 74 cases/148 cores

Details: Hepatocellular carcinoma tissue microarray with normal tissue, containing 60 cases of hepatocellular carcinoma, 10 cholangiocarcinoma, plus 4 normal liver tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:
Outright purchase
Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

  • Specification sheet
  • Overlapping case
  • Download specifications
Legend:
Car-Cardia Eso-Fsophagus
  • *(*)
  • Normal(*)
  • Malignant(IB)
  • Malignant(II)
  • Malignant(IIIA)
  • Malignant(IIIB)
  • Malignant(III)
  • Malignant(IVA)
TISSUE ARRAYS
DLV1481
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
B
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
C
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
D
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
E
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
F
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
G
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
H
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
I
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
-
J
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
Liv
DLV1481
  • Age:
  • Sex:
  • Organ/Anatomic Site:
  • Pathology diagnosis:
  • Grade:
  • TNM:
  • Stage:
  • Tissue ID.:
  • Type:
Pos No. Age Sex Organ/Anatomic Site Pathology diagnosis Grade TNM Stage Type Tumor size Ki-67 CK18
A1
1 52 M Liver Hepatocellular carcinoma with necrosis (sparse) 1 T3N0M0 IIIA Malignant 14*9*5.5 - +,60%
A2
2 38 M Liver Hepatocellular carcinoma 1 T3N0M0 III Malignant 9*8*5.5 +,5% +++,100%
A3
3 45 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 5.0*4.0*4.0 - +++,100%
A4
4 41 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 6.0*5.0*4.0 - ++,90%
A5
5 69 M Liver Hepatocellular carcinoma 1--2 T3aN0M0 IIIA Malignant 12*9*9 - ++,80%
A6
6 36 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 12*8*7.5 - ++,70%
A7
7 72 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*5.0*3.5 - ++,80%
A8
8 49 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 10*3*2.5 - ++,90%
A9
9 43 M Liver Hepatocellular carcinoma (sparse) 2 T2N0M0 II Malignant - - ++,90%
A10
10 40 M Liver Hepatocellular carcinoma 2 T3N1M0 IVA Malignant - - +++,100%
A11
11 77 M Liver Hepatocellular carcinoma 2 T3aN0M0 IIIA Malignant 6.0*5.0*5.0 - ++,80%
A12
12 63 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 4.0*3.5*2.5 - +,60%
A13
13 51 M Liver Hepatocellular carcinoma 2 T3aN1M0 IVA Malignant 6cm - +,40%
A14
14 56 M Liver Hepatocellular carcinoma 1--2 T3N0M0 IIIA Malignant 9*7*5.5 - +,50%
A15
15 48 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - +,15% +,10%
B1
16 52 M Liver Hepatocellular carcinoma 1 T3N0M0 IIIA Malignant 14*9*5.5 - +,60%
B2
17 38 M Liver Hepatocellular carcinoma 1 T3N0M0 III Malignant 9*8*5.5 +,5% +++,100%
B3
18 45 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 5.0*4.0*4.0 - +++,100%
B4
19 41 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 6.0*5.0*4.0 - ++,90%
B5
20 69 M Liver Hepatocellular carcinoma 1--2 T3aN0M0 IIIA Malignant 12*9*9 - ++,80%
B6
21 36 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 12*8*7.5 - ++,70%
B7
22 72 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*5.0*3.5 - ++,80%
B8
23 49 M Liver Hepatocellular carcinoma 1 T2N0M0 II Malignant 10*3*2.5 - ++,90%
B9
24 43 M Liver Hepatocellular carcinoma (sparse) 2 T2N0M0 II Malignant - - ++,90%
B10
25 40 M Liver Hepatocellular carcinoma 2 T3N1M0 IVA Malignant - - +++,100%
B11
26 77 M Liver Hepatocellular carcinoma 2 T3aN0M0 IIIA Malignant 6.0*5.0*5.0 - ++,80%
B12
27 63 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 4.0*3.5*2.5 - 掉片
B13
28 51 M Liver Hepatocellular carcinoma 2 T3aN1M0 IVA Malignant 6cm - +,40%
B14
29 56 M Liver Hepatocellular carcinoma 1--2 T3N0M0 IIIA Malignant 9*7*5.5 - ++,90%
B15
30 48 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - +,15% +,10%
C1
31 53 F Liver Hepatocellular carcinoma 2 T1bN0M0 IB Malignant 6*4*3 +,5% ++,80%
C2
32 60 M Liver Hepatocellular carcinoma 2 T3aN0M0 IIIA Malignant 11*9*4.5 +,15% ++,100%
C3
33 65 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 15*10*9 - +,80%
C4
34 49 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 8*4*2 - +,60%
C5
35 45 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - +,5% ++,80%
C6
36 57 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.5*5.0*3.5 +,5% +++,100%
C7
37 32 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5*4*3 - +,30%
C8
38 40 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 15*11*16 - ++,70%
C9
39 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - - ++,70%
C10
40 63 M Liver Hepatocellular carcinoma 2 T3N0M0 III Malignant - - +,60%
C11
41 48 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 8*6*4.5 - +,80%
C12
42 62 M Liver Hepatocellular carcinoma (interstitial) 2 T3N0M0 IIIA Malignant 10*5*4 - -
C13
43 74 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 10*9*8.5 - +,10%
C14
44 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 9*4*2.5 - ++,70%
C15
45 24 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5*4*2.5 - +++,100%
D1
46 53 F Liver Hepatocellular carcinoma 2 T1bN0M0 IB Malignant 6*4*3 +,5% ++,70%
D2
47 60 M Liver Hepatocellular carcinoma 2 T3aN0M0 IIIA Malignant 11*9*4.5 +,15% ++,90%
D3
48 65 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 15*10*9 - ++,70%
D4
49 49 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 8*4*2 - +,60%
D5
50 45 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - - ++,70%
D6
51 57 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.5*5.0*3.5 - +++,100%
D7
52 32 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5*4*3 +,2% +,70%
D8
53 40 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 15*11*16 - ++,90%
D9
54 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - - ++,70%
D10
55 63 M Liver Hepatocellular carcinoma 2 T3N0M0 III Malignant - - +,60%
D11
56 48 M Liver Hepatocellular carcinoma (sparse) 2 T3N0M0 IIIA Malignant 8*6*4.5 +,5% +,60%
D12
57 62 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 10*5*4 +,15% +,70%
D13
58 74 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 10*9*8.5 - -
D14
59 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 9*4*2.5 - +,60%
D15
60 24 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5*4*2.5 - ++,90%
E1
61 51 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 8*4*2 - +,40%
E2
62 54 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 12*7.5*3.5 +,3% ++,80%
E3
63 45 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 12*8*4.5 ++,25% +,70%
E4
64 60 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - - +,70%
E5
65 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*4.0*2.0 +,3% +,10%
E6
66 53 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.0*5.0*4.0 +,5% ++,90%
E7
67 57 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 7.5*4*3 - +,10%
E8
68 62 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 4*3*3 - +,30%
E9
69 55 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 10*5*4.8 +,5% ++,90%
E10
70 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 11*5*3.5 +,3% ++,80%
E11
71 52 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.0*4.5*4.5 +,3% +,70%
E12
72 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 7*7*6 - +,70%
E13
73 62 M Liver Hepatocellular carcinoma 2--3 T3N0M0 IIIA Malignant 6.0*4.0*3.0 - ++,80%
E14
74 65 F Liver Hepatocellular carcinoma 2--3 T2N0M0 II Malignant 15*8.5*3.5 - ++,90%
E15
75 63 M Liver Hepatocellular carcinoma 2--3 T3N0M0 IIIA Malignant - - +,70%
F1
76 51 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 8*4*2 - +,60%
F2
77 54 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 12*7.5*3.5 - ++,80%
F3
78 45 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 12*8*4.5 ++,25% +,70%
F4
79 60 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant - - +,70%
F5
80 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 5.5*4.0*2.0 - +,10%
F6
81 53 F Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 6.0*5.0*4.0 +,10% ++,90%
F7
82 57 M Liver Hepatocellular carcinoma 2 T3N0M0 IIIA Malignant 7.5*4*3 - +,20%
F8
83 62 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 4*3*3 - +,30%
F9
84 55 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 10*5*4.8 +,5% ++,60%
F10
85 50 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 11*5*3.5 - ++,80%
F11
86 52 F Liver Hepatocellular carcinoma with necrosis 2 T2N0M0 II Malignant 6.0*4.5*4.5 +,5% ++,70%
F12
87 58 M Liver Hepatocellular carcinoma 2 T2N0M0 II Malignant 7*7*6 - +,70%
F13
88 62 M Liver Hepatocellular carcinoma 2--3 T3N0M0 IIIA Malignant 6.0*4.0*3.0 +,5% ++,80%
F14
89 65 F Liver Hepatocellular carcinoma 2--3 T2N0M0 II Malignant 15*8.5*3.5 - ++,90%
F15
90 63 M Liver Hepatocellular carcinoma 2--3 T3N0M0 IIIA Malignant - - +,50%
G1
91 60 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 8.0*7*5 - +,10%
G2
92 38 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 15.5*12*4 +,5% ++,60%
G3
93 27 F Liver Hepatocellular carcinoma 2--3 T4N0M0 IIIB Malignant - - 掉片
G4
94 41 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant - +,2% ++,80%
G5
95 57 M Liver Hepatocellular carcinoma with necrosis (sparse) 3 T3N0M0 IIIA Malignant 17*6*4 +,5% +,20%
G6
96 45 M Liver Hepatocellular carcinoma (degeneration) 3 T2N0M0 II Malignant - - -
G7
97 47 M Liver Hepatocellular carcinoma with necrosis 3 T2N0M0 II Malignant 3.5*2.5*2.2 - ++,60%
G8
98 49 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 10*8*4 - ++,80%
G9
99 38 M Liver Hepatocellular carcinoma with degeneration 3 T2N0M0 II Malignant - 掉片 掉片
G10
100 51 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 14*8*4.5 +,5% ++,70%
G11
101 51 M Liver Hepatocellular carcinoma with necrosis 2 T3N0M0 IIIA Malignant 9x6x5.5 - +,30%
G12
102 62 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant - +,5% ++,70%
G13
103 60 F Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 7*6*5 +,10% +,90%
G14
104 47 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 8.5*6.0*3.5 - +,70%
G15
105 53 M Liver Hepatocellular carcinoma 3--4 T2N0M0 II Malignant 10*6*5 - -
H1
106 60 M Liver Hepatocellular carcinoma with sparse necrosis 3 T3N0M0 IIIA Malignant 8.0*7*5 - +,10%
H2
107 38 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 15.5*12*4 +,5% ++,60%
H3
108 27 F Liver Hepatocellular carcinoma 2--3 T4N0M0 IIIB Malignant - - 掉片
H4
109 41 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant - +,3% ++,80%
H5
110 57 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 17*6*4 - +,20%
H6
111 45 M Liver Hepatocellular carcinoma with degeneration 3 T2N0M0 II Malignant - - -
H7
112 47 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant 3.5*2.5*2.2 - +,50%
H8
113 49 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 10*8*4 - ++,80%
H9
114 38 M Liver Hepatocellular carcinoma 3 T2N0M0 II Malignant - - 掉片
H10
115 51 M Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 14*8*4.5 +,5% ++,70%
H11
116 51 M Liver Hepatocellular carcinoma with degeneration 3 T3N0M0 IIIA Malignant 9x6x5.5 - +,40%
H12
117 62 M Liver Hepatocellular carcinoma (sparse) 3 T2N0M0 II Malignant - +,5% +,30%
H13
118 60 F Liver Hepatocellular carcinoma 3 T3N0M0 IIIA Malignant 7*6*5 +,10% +,60%
H14
119 47 M Liver Hepatocellular carcinoma with necrosis 3 T3N0M0 IIIA Malignant 8.5*6.0*3.5 - ++,60%
H15
120 53 M Liver Hepatocellular carcinoma 3--4 T2N0M0 II Malignant 10*6*5 - +,5%
I1
121 50 F Liver Cholangiocarcinoma (sparse) 2 T3N1M0 IIIB Malignant 5 - ++,80%
I2
122 46 F Liver Cholangiocarcinoma 2 T2N1M0 IIIB Malignant - +,10% ++,80%
I3
123 54 M Liver Cholangiocarcinoma with necrosis 2 T3N1M0 IIIB Malignant 9 +,10% ++,90%
I4
124 51 F Liver Cholangiocarcinoma with necrosis 2 T3N1M0 IIIB Malignant 7 - +,30%
I5
125 52 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant 6.5 +,5% +,80%
I6
126 62 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant 4.5 - ++,90%
I7
127 60 F Liver Cholangiocarcinoma 2--3 T3N0M0 IIIA Malignant - +,3% +,30%
I8
128 62 M Liver Cholangiocarcinoma 2--3 T2aN0M0 II Malignant 6 +,10% ++,90%
I9
129 51 M Liver Cholangiocarcinoma with degeneration 3 T3N1M0 IIIB Malignant - - 掉片
I10
130 70 F Liver Cholangiocarcinoma (sparse) 3 T3N1M0 IIIB Malignant 10*10 - +,30%
I11
131 55 M Liver Liver tissue (mild inflammation) * * * Normal - +,3% ++,80%
I12
132 6 Mon. F Liver Liver tissue (moderate inflammation) * * * Normal - - +++,80%
I13
133 23 M Liver Liver tissue (mild inflammation) * * * Normal - - ++,80%
I14
134 38 M Liver Liver tissue (mild inflammation) * * * Normal - - ++,80%
I15
135 - - - Blank * * * * - - -
J1
136 50 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant 5 - ++,80%
J2
137 46 F Liver Cholangiocarcinoma (sparse) 2 T2N1M0 IIIB Malignant - +,5% ++,80%
J3
138 54 M Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant 9 +,5% ++,90%
J4
139 51 F Liver Cholangiocarcinoma (sparse) 2 T3N1M0 IIIB Malignant 7 - +,30%
J5
140 52 F Liver Cholangiocarcinoma 2 T3N1M0 IIIB Malignant 6.5 +,5% +,80%
J6
141 62 F Liver Cholangiocarcinoma (degeneration) 2 T3N1M0 IIIB Malignant 4.5 - ++,90%
J7
142 60 F Liver Cholangiocarcinoma 2--3 T3N0M0 IIIA Malignant - +,1% +,30%
J8
143 62 M Liver Cholangiocarcinoma with sparse necrosis 2--3 T2aN0M0 II Malignant 6 +,15% ++,90%
J9
144 51 M Liver Cholangiocarcinoma with degeneration 3 T3N1M0 IIIB Malignant - 掉片 掉片
J10
145 70 F Liver Cholangiocarcinoma (sparse) 3 T3N1M0 IIIB Malignant 10*10 - +,30%
J11
146 55 M Liver Liver tissue (mild inflammation) * * * Normal - - ++,80%
J12
147 6 Mon. F Liver Liver tissue (moderate inflammation) * * * Normal - - +++,80%
J13
148 23 M Liver Liver tissue (mild inflammation) * * * Normal - - ++,80%
J14
149 38 M Liver Liver tissue (mild inflammation) * * * Normal - - ++,80%
Find overlapping cases with this tissue array:
  • DLV1481
    File Format: .xls
    Release Date: 2025-01-17 15:53:47
    Download
1.069661s